Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 6/20 | 0.55 |
| ▸ | FNTA | P49354 | 8/20 | 0.44 |
| ▸ | FNTB | P49356 | 6/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29255678 | 1.00 | BTN3A1 (0.55) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL4553437 | 1.00 | BTN3A1 (0.55) | BTN3A1FNTAFNTBPGGT1B | |
| Allyl Pyrophosphate SCHEMBL1075959 | 0.96 | BTN3A1 (0.59) | BTN3A1FNTAFNTBPGGT1B | |
| Allyl Pyrophosphate SCHEMBL9482750 | 0.94 | BTN3A1 (0.57) | BTN3A1FNTAFNTBPGGT1B | |
| Allyl Pyrophosphate SCHEMBL28997349 | 0.94 | BTN3A1 (0.57) | BTN3A1FNTAFNTBPGGT1B | |
| Allyl Pyrophosphate SCHEMBL4052782 | 0.92 | BTN3A1 (0.55) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL6695477 | 0.86 | BTN3A1 (0.42) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL28997347 | 0.84 | BTN3A1 (0.43) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL174096 | 0.82 | BTN3A1 (0.40) | BTN3A1FNTAFNTBPGGT1B | |
| SCHEMBL14941354 | 0.82 | BTN3A1 (0.44) | BTN3A1FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5334485-A | Containing n-heterocyclic ring | THE CHROMALINE CORPORATION (US) | 1994-08-02 | — | — | US | claimed |
| US-5334485-A | Containing n-heterocyclic ring | THE CHROMALINE CORPORATION (US) | 1994-08-02 | — | — | US | disclosed |